Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Little Evidence of Modified Genetic Effect of rs16969968 on Heavy Smoking Based on Age of Onset of Smoking

Christine Adjangba, View ORCID ProfileRichard Border, Pamela N. Romero Villela, Marissa A. Ehringer, View ORCID ProfileLuke M. Evans
doi: https://doi.org/10.1101/2020.04.22.20071407
Christine Adjangba
1Institute for Behavioral Genetics, University of Colorado Boulder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Border
1Institute for Behavioral Genetics, University of Colorado Boulder
2Department of Applied Mathematics, University of Colorado Boulder
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard Border
Pamela N. Romero Villela
1Institute for Behavioral Genetics, University of Colorado Boulder
3Department of Psychology & Neuroscience, University of Colorado Boulder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marissa A. Ehringer
1Institute for Behavioral Genetics, University of Colorado Boulder
4Department of Integrative Physiology, University of Colorado Boulder
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luke M. Evans
1Institute for Behavioral Genetics, University of Colorado Boulder
5Department of Ecology & Evolutionary Biology, University of Colorado Boulder
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luke M. Evans
  • For correspondence: luke.m.evans{at}colorado.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Tobacco smoking is the leading cause of preventable death globally. Smoking quantity, measured in cigarettes per day (CPD), is influenced both by the age of onset of regular smoking (AOS) and by genetic factors, including a strong effect of the non-synonymous single nucleotide polymorphism rs16969968. A previous study by Hartz et al. reported an interaction between these two factors, whereby rs16969968 risk allele carriers who started smoking earlier showed increased risk for heavy smoking compared to those who started later. This finding has yet to be replicated in a large, independent sample. We performed a preregistered, direct replication attempt of the rs16969968×AOS interaction on smoking quantity in 128,383 unrelated individuals from the UK Biobank, meta-analyzed across ancestry groups. We fit statistical association models mirroring the original publication as well as formal interaction tests on multiple phenotypic and analytical scales. We replicated the main effects of rs16969968 and AOS on CPD but failed to replicate the interaction using previous methods. Nominal significance of the rs16969968×AOS interaction term depended strongly on the scale of analysis and the particular phenotype, as did associations stratified by early/late AOS. No interaction tests passed genome-wide correction (α=5e-8), and all estimated interaction effect sizes were much smaller in magnitude than previous estimates. We failed to replicate the strong rs16969968×AOS interaction effect previously reported. If such gene-moderator interactions influence complex traits, they likely depend on scale of measurement, and current biobanks lack the power to detect significant genome-wide associations given the minute effect sizes expected.

IMPLICATIONS We failed to replicate the strong rs16969968×AOS interaction effect on smoking quantity previously reported. If such gene-moderator interactions influence complex traits, current biobanks lack the power to detect significant genome-wide associations given the minute effect sizes expected. Furthermore, many potential interaction effects are likely to depend on the scale of measurement employed.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

https://osf.io/ynh2j

Funding Statement

Ms. Adjangba was supported by the Summer Multicultural Access to Research Training Program at the University of Colorado. Drs. Evans and Border are supported by National Institute of Mental Health R01 MH100141-06 (PI: Matthew C. Keller) and Dr. Evans is supported by National Institute on Drug Abuse R01 DA044283-01A1 (PI: Scott I. Vrieze).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Clarification of the importance of validation and replication of association tests. Utilizing the entire UK Biobank sample across all ancestries.

Data Availability

The data used are available through the UK Biobank.

https://www.ukbiobank.ac.uk/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Little Evidence of Modified Genetic Effect of rs16969968 on Heavy Smoking Based on Age of Onset of Smoking
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Little Evidence of Modified Genetic Effect of rs16969968 on Heavy Smoking Based on Age of Onset of Smoking
Christine Adjangba, Richard Border, Pamela N. Romero Villela, Marissa A. Ehringer, Luke M. Evans
medRxiv 2020.04.22.20071407; doi: https://doi.org/10.1101/2020.04.22.20071407
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Little Evidence of Modified Genetic Effect of rs16969968 on Heavy Smoking Based on Age of Onset of Smoking
Christine Adjangba, Richard Border, Pamela N. Romero Villela, Marissa A. Ehringer, Luke M. Evans
medRxiv 2020.04.22.20071407; doi: https://doi.org/10.1101/2020.04.22.20071407

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)